[1] |
Robbins, K.S.; Krause, M.; Nguyen, A.P.; Almehlisi, A.; Meier, A.; Schmidt, U. Peripartum cardiomyopathy: current options for treatment and cardiovascular support. J. Cardiothorac. Vasc. Anesth. 2019, 33, 2814–2825.
|
[2] |
Isogai, T.; Kamiya, C.A. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality. Int. Heart J. 2019, 60, 503–511.
|
[3] |
Sliwa, K.; Hilfiker-Kleiner, D.; Mebazaa, A.; Petrie, M.C.; Maggioni, A.P.; Regitz-Zagrosek, V.; Schaufelberger, M.; Tavazzi, L.; van Veldhuisen, D.J.; Roos-Hesslink, J.W.; Shah, A.J.; Seferovic, P.M.; Elkayam, U.; van Spaendonck-Zwarts, K.; Bachelier-Walenta, K.; Mouquet, F.; Kraigher-Krainer, E.; Hall, R.; Ponikowski, P.; McMurray, J.J.V.; Pieske, B. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur. J. Heart Fail. 2014, 16, 583–591.
|
[4] |
Irizarry, O.C.; Levine, L.D.; Lewey, J.; Boyer, T.; Riis, V.; Elovitz, M.A.; Arany, Z. Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiol. 2017, 2, 1256–1260.
|
[5] |
Sliwa, K.; Petrie, M.C.; Hilfiker-Kleiner, D.; Mebazaa, A.; Jackson, A.; Johnson, M.R.; van der Meer, P.; Mbakwem, A.; Bauersachs, J. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur. J. Heart Fail. 2018, 20, 951–962.
|
[6] |
Davis, M.B.; Arany, Z.; McNamara, D.M.; Goland, S.; Elkayam, U. Peripartum cardiomyopathy. J. Am. Coll. Cardiol. 2020, 75, 207–221.
|
[7] |
Bauersachs, J.; König, T.; van der Meer, P.; Petrie, M.C.; Hilfiker-Kleiner, D.; Mbakwem, A.; Hamdan, R.; Jackson, A.M.; Forsyth, P.; de Boer, R.A.; Mueller, C.; Lyon, A.R.; Lund, L.H.; Piepoli, M.F.; Heymans, S.; Chioncel, O.; Anker, S.D.; Ponikowski, P.; Seferovic, P.M.; Johnson, M.R.; Mebazaa, A.; Sliwa, K. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur. J. Heart Fail. 2019, 21, 827–843.
|
[8] |
Lin, Y.K.; Chen, Y.C.; Chen, Y.A.; Huang, J.H.; Chen, S.A.; Chen, Y.J. Levosimendan differentially modulates electrophysiological activities of sinoatrial nodes, pulmonary veins, and the left and right atria. J. Cardiovasc. Electrophysiol. 2018, 29, 1150–1158.
|
[9] |
Papp, Z.; Agostoni, P.; Alvarez, J.; Bettex, D.; Bouchez, S.; Brito, D.; Černý, V.; Comin-Colet, J.; Crespo-Leiro, M.G.; Delgado, J.F.; Édes, I.; Eremenko, A.A.; Farmakis, D.; Fedele, F.; Fonseca, C.; Fruhwald, S.; Girardis, M.; Guarracino, F.; Harjola, V.P.; Heringlake, M.; Herpain, A.; Heunks, L.M.; Husebye, T.; Ivancan, V.; Karason, K.; Kaul, S.; Kivikko, M.; Kubica, J.; Masip, J.; Matskeplishvili, S.; Mebazaa, A.; Nieminen, M.S.; Oliva, F.; Papp, J.G.; Parissis, J.; Parkhomenko, A.; Põder, P.; Pölzl, G.; Reinecke, A.; Ricksten, S.E.; Riha, H.; Rudiger, A.; Sarapohja, T.; Schwinger, R.H.; Toller, W.; Tritapepe, L.; Tschöpe, C.; Wikström, G.; von Lewinski, D.; Vrtovec, B.; Pollesello, P. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card. Fail. Rev. 2020, 6, e19.
|
[10] |
Michaels, A.D.; McKeown, B.; Kostal, M.; Vakharia, K.T.; Jordan, M.V.; Gerber, I.L.; Foster, E.; Chatterjee, K. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation. 2005, 111, 1504–1509.
|
[11] |
Bouchez, S.; Fedele, F.; Giannakoulas, G.; Gustafsson, F.; Harjola, V.; Karason, K.; Kivikko, M.; von Lewinski, D.; Oliva, F.; Papp, Z.; Parissis, J.; Pollesello, P.; Pölzl, G.; Tschöpe, C. Levosimendan in acute and advanced heart failure: an expert perspective on posology and therapeutic application. Cardiovasc. Drugs Ther. 2018, 32, 617–624.
|
[12] |
Farmakis, D.; Alvarez, J.; Gal, T.B.; Brito, D.; Fedele, F.; Fonseca, C.; Gordon, A.C.; Gotsman, I.; Grossini, E.; Guarracino, F.; Harjola, V.P.; Hellman, Y.; Heunks, L.; Ivancan, V.; Karavidas, A.; Kivikko, M.; Lomivorotov, V.; Longrois, D.; Parissis, J. Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper. Int. J. Cardiol. 2016, 222, 303–312.
|